Research News and Research

RSS

Insulin induces formation of new elastin in cultures of human aortic smooth muscle cells

New research reveals that insulin applied in therapeutic doses selectively stimulates the formation of new elastic fibers in cultures of human aortic smooth muscle cells.

10 Jan 2012

Roundup: Iowa weighs mental health care changes; Ariz. clinic seeks to cut ER costs

Republican and Democratic legislators and Gov. Terry Branstad have said they want to reform Iowa's mental health system to reduce waiting lists and provide more equitable services. Currently, each of Iowa's counties performs or contracts for mental health services for indigent residents. Critics contend the 99-county system has led to pockets of inferior, inequitable service, particularly in rural areas.

10 Jan 2012

Life Technologies takes orders for new benchtop Ion Proton Sequencer

Life Technologies Corporation today announced it is taking orders for the new benchtop Ion Proton Sequencer that is designed to sequence the entire human genome in a day for $1,000.

10 Jan 2012

Nicotine patch may boost memory in individuals with MCI

Wearing a nicotine patch may help improve memory loss in older adults with mild cognitive impairment, according to a study published today in Neurology, the medical journal of the American Academy of Neurology.

10 Jan 2012

CNBG, Aeras reach final agreement to develop new TB vaccines

The global fight against the tuberculosis epidemic receives a boost today as Aeras and the China National Biotec Group (CNBG) announce that they have reached final agreement to jointly develop new tuberculosis (TB) vaccines.

10 Jan 2012

Fallujah doctors say chemicals from U.S. weapons to blame for high levels of birth defects

"While the U.S. military has formally withdrawn from Iraq, doctors and residents of Fallujah are blaming weapons like depleted uranium and white phosphorous used during two devastating U.S. attacks on Fallujah in 2004 for what are being described as 'catastrophic' levels of birth defects and abnormalities," Al Jazeera reports.

10 Jan 2012

Wolters Kluwer Health announces release of Oncology Times app for the iPad

Wolters Kluwer Health announced today the release of Oncology Times app for the iPad. Now cancer care professionals and others can access the latest oncology news and trends with the dynamic new Oncology Times app. Oncology Times is published by Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health.

10 Jan 2012

Study identifies netrin-1 as novel target for atherosclerosis

A new study by NYU Langone Medical Center researchers identified a new culprit that leads to atherosclerosis, the accumulation of fat and cholesterol that hardens into plaque and narrows arteries. The research, published online by Nature Immunology on January 8, 2012, explains why cholesterol-laden, coronary artery disease-causing cells called macrophages, accumulate in artery plaques.

10 Jan 2012

Political turmoil in Yemen causing breakdown of social services, increased threats to child welfare

"Yemen's populist uprising and the political crisis that followed have pushed the country to the brink of a humanitarian emergency, according to the United Nations and aid agencies," the Washington Post reports, noting that "children have been hit especially hard."

9 Jan 2012

JHM, Healthways partner for innovative weight-loss program

Building on the success of recent Hopkins research showing obese participants were able to lose significant weight and keep it off for two years using telephone coaching and a specially designed website, Johns Hopkins Medicine is collaborating with Healthways to help bring the innovative weight-loss program to many more who could benefit from it.

9 Jan 2012

Neomatrix, UND partner to develop technology for early detection of breast cancer

The University of North Dakota and Neomatrix, LLC, have signed an exclusive agreement to develop technology for the early detection of breast cancer using the company's HALO Breast Pap Test device.

9 Jan 2012

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 12-week phase IIb clinical trial of IDX184, the Company's lead product candidate for the treatment of hepatitis C virus (HCV) infection.

9 Jan 2012

First study to investigate driving in teens with high-functioning autism disorder

In the first study to investigate driving as it relates to teens with a high-functioning autism disorder (HFASD), child development and teen driving experts at The Children's Hospital of Philadelphia's Center for Child Injury Prevention Studies found that two-thirds of teenagers with a high-functioning autism spectrum disorder (HFASD) who are of legal driving age in their state are currently driving or plan to drive.

9 Jan 2012

Combination of GXR and psychostimulant safe and effective for children with ADHD

While pharmacologic agents have a demonstrated efficacy in children with Attention-deficit/hyperactivity disorder (ADHD), some children have suboptimal response to a single pharmacologic agent.

9 Jan 2012

Baxter submits GAMMAGARD LIQUID sBLA to FDA for treatment of MMN

Baxter International Inc. today announced that the company has submitted a supplemental biologics license application (sBLA) to the U.S. Food and Drug Administration (FDA) for approval of GAMMAGARD LIQUID 10% for the treatment of multifocal motor neuropathy.

From Baxter International Inc. 9 Jan 2012

The sharpness of the brain dulls beyond 45: Study

Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.

9 Jan 2012

Blacklisted British doctor sues journal

A British doctor who lost his medical license in the U.K. in 2010 and who was accused in a journal last year of publishing bogus research filed a defamation suit this week in state District Court in Travis County.

9 Jan 2012

At least two alcohol free days per week recommended

Those who drink regularly are advised to abstain from alcohol for at least two days a week. A committee of MPs has found current drinking guidelines are unclear and need to be revised. Currently the “sensible limits” for drinking, which were defined 25 years ago, are 21 units of alcohol a week for men and 14 for women. But the report by the Science and Technology Committee found many people do not know how much a unit is.

9 Jan 2012

Novel class of nanoparticles hold promise as a potential vehicle for drug delivery

In the images of fruit flies, clusters of neurons are all lit up, forming a brightly glowing network of highways within the brain. It’s exactly what University at Buffalo researcher Shermali Gunawardena was hoping to see: It meant that ORMOSIL, a novel class of nanoparticles, had successfully penetrated the insects’ brains. And even after long-term exposure, the cells and the flies themselves remained unharmed.

9 Jan 2012

Oxygen Biotherapeutics to commence study to determine efficacy of Dermacyte in relieving Histamine induced pruritus

Oxygen Biotherapeutics, Inc. has announced that enrollment for the company’s first dermatological study will begin later this month at St. John’s Medical College Hospital in Bangalore, India. The company received formal approval from the hospital’s Ethics Review Board in December. This study is the first of a series of trials scheduled for 2012 to explore the efficacy of Dermacyte to treat a variety of dermatological conditions, such as allergic contact dermatitis, psoriasis and acne.

9 Jan 2012

Research News and Research

Insulin induces formation of new elastin in cultures of human aortic smooth muscle cells

Roundup: Iowa weighs mental health care changes; Ariz. clinic seeks to cut ER costs

Life Technologies takes orders for new benchtop Ion Proton Sequencer

Nicotine patch may boost memory in individuals with MCI

CNBG, Aeras reach final agreement to develop new TB vaccines

Fallujah doctors say chemicals from U.S. weapons to blame for high levels of birth defects

Wolters Kluwer Health announces release of Oncology Times app for the iPad

Study identifies netrin-1 as novel target for atherosclerosis

Political turmoil in Yemen causing breakdown of social services, increased threats to child welfare

JHM, Healthways partner for innovative weight-loss program

Neomatrix, UND partner to develop technology for early detection of breast cancer

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

First study to investigate driving in teens with high-functioning autism disorder

Combination of GXR and psychostimulant safe and effective for children with ADHD

Baxter submits GAMMAGARD LIQUID sBLA to FDA for treatment of MMN

The sharpness of the brain dulls beyond 45: Study

Blacklisted British doctor sues journal

At least two alcohol free days per week recommended

Novel class of nanoparticles hold promise as a potential vehicle for drug delivery

Oxygen Biotherapeutics to commence study to determine efficacy of Dermacyte in relieving Histamine induced pruritus

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery